Since the company registration one hundred and seventy-five events have happened. The last three records are Total exemption small company accounts made up to 31 March 2016; Confirmation statement made on 20 November 2016 with updates; Termination of appointment of John Crispin Kirkman as a secretary on 8 March 2016. The most likely internet sites of THERYTE LIMITED are www.theryte.co.uk, and www.theryte.co.uk. The predicted number of employees is 1 to 10. The company’s age is twenty-eight years and one months. The distance to to Bristol Temple Meads Rail Station is 4.3 miles; to Bath Spa Rail Station is 6.6 miles; to Filton Abbey Wood Rail Station is 6.9 miles; to Bristol Parkway Rail Station is 7.1 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Theryte Limited is a Private Limited Company. The company registration number is 03468869. Theryte Limited has been working since 20 November 1997. The present status of the company is Active - Proposal to Strike off. The registered address of Theryte Limited is 2 Temple Street Keynsham Bristol Bs31 1eg. The company`s financial liabilities are £229.04k. It is £2.81k against last year. The cash in hand is £0.22k. It is £-0.41k against last year. And the total assets are £0.98k, which is £-1.72k against last year. DOHRN, Peter John is a Director of the company. ROWBOTHAM, Nigel Henry is a Director of the company. Secretary BISHOP, Robert John, Dr has been resigned. Secretary KIRKMAN, John Crispin has been resigned. Nominee Secretary SWIFT INCORPORATIONS LIMITED has been resigned. Director BISHOP, Robert John, Dr has been resigned. Director JOHNSTONE, Robert Alexander Walker, Professor has been resigned. Director LAMONT, John Victor has been resigned. Director SCHMIDT, Gunter Herbert, Dr has been resigned. Director SLAGEL, Dean Marc has been resigned. Director WARENIUS, Hilmar Meek, Prof has been resigned. Nominee Director INSTANT COMPANIES LIMITED has been resigned. The company operates in "Research and experimental development on biotechnology".